Thank you. I see where you are coming from. I do however disagree with your interpretation that they only took 25 samples:
"I don't know why only 25 patients had serum levels (taken), I just know that that was reported as what as what was available - had they had 26 or 27 it would have been better to use all they had - bigger data set better stats - but they didn't so they used the 25 they had."
They collected 40 samples and therefore had a bigger data set, except they had to filter the 40-patient data set "post-hoc" to get the ones with the MAP scores supporting their hypothesis - and for that they could only use 25.
Just like your patent point (which was valid), this might seem like a petty point, but saying they only took 25 patient serum levels when they took 40, especially since you said "they wouldn't arbitrarily leave some out - which one's would they chose to leave out", is in my opinion incorrect as they made a conscious decision to leave an additional 15 data points out aince they didn't fit into their new/reversed hypothesis.
Bottom line however, you say they only have 11 daya points which I agree would make it very difficult to avoid a CRL #3 as there is no new data to present, while I say, there Pilot study generated additional dat, giving them more thanc11 data points.
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
Ann: Investor Presentation, page-575
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M |
Open | High | Low | Value | Volume |
20.5¢ | 21.5¢ | 20.0¢ | $13.43K | 65.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 109917 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 9225 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 109917 | 0.200 |
2 | 68825 | 0.195 |
3 | 122713 | 0.190 |
3 | 65055 | 0.180 |
3 | 7139 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 9225 | 2 |
0.255 | 187726 | 1 |
0.270 | 30000 | 1 |
0.280 | 8209 | 2 |
0.285 | 60000 | 1 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online